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ObesityAbstract Obstructive sleep apnea (OSA) and asthma are highly prevalent respiratory disorders
that share several risk factors and are frequently comorbid. Multiple mechanisms have been postu-
lated to explain this frequent coexistence, which is recently referred to as the ‘‘alternative overlap
syndrome’’. Moreover, OSA is generally linked to worse asthma outcomes.
Objectives: First, to assess the prevalence of OSA in a group of asthmatics. Second, to evaluate
the potential risk factors underlying the development of OSA in these patients. Third, to determine
the effect of this overlap on asthma control.
Methods: Polysomnography was done for 30 asthmatics and 12 controls. Demographics, spiro-
metry, comorbidities and clinical data were collected. Asthma control was assessed according to the
latest GINA guidelines.
Results: OSA deﬁned by an AHI of P5 events/h was present in 18 (60%) asthmatics and 2
(17%) controls. Regression analysis revealed that high body mass index (BMI), coexistent gastroe-
sophageal reﬂux disease (GERD) and asthma severity (FEV1%) are signiﬁcant independent predic-
tors for the development of OSA in asthmatics (p= 0.03, 0.034, and <0.001 respectively).
Moreover, the presence of OSA in asthmatic patients was signiﬁcantly associated with worse asth-
ma control (p< 0.001).
Conclusion: A high index of suspicion is warranted for the overlap of OSA and asthma, par-
ticularly in the presence of obesity, GERD, and in patients with severe asthma. Individualized ther-
apy addressing these moderating factors is warranted for optimal health outcomes. Recognition and
treatment of OSA in asthmatics is an important element in improving asthma control.
ª 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Obstructive sleep apnea (OSA) and asthma are highly
prevalent chronic respiratory disorders that share several risk
factors and are frequently comorbid [1]. Both symptoms ofOSA and diagnosed OSA are more frequent in clinical popula-
tions with asthma compared to other populations [2–4].
In addition to overlapping risk factors, multiple evi-
dence-based and hypothetical mechanisms have been postu-
lated to explain the frequent coexistence of OSA and
asthma, also referred to as the ‘‘alternative overlap syn-
drome’’ [4–7].
426 M. Zidan et al.Asthma is an inﬂammatory disease of the lower respiratory
tract, manifesting as intermittent constriction of the bronchial
airways. Obstructive sleep apnea (OSA), on the other hand, is
a state-dependent condition that is characterized by intermit-
tent obstruction of the upper airway during sleep leading to
hypoxemia and sleep fragmentation [8]. The pathophysiology
of these two conditions seems to overlap signiﬁcantly, as air-
way obstruction, inﬂammation, obesity, and several other fac-
tors are implicated in the development of both diseases [5]. On
the other hand it has been suggested that asthma comorbidi-
ties, such as GERD, and medications may also contribute to
the development of OSA [9]. In this setting, a more speciﬁc
understanding of what increases predisposition for OSA in
asthma could be useful.
Moreover, OSA is generally linked to worse asthma out-
comes. The effects of the direct pathophysiologic consequences
of OSA (e.g., chronic intermittent hypoxemia, circadian alter-
ation of autonomic functions, and increased intrathoracic
pressure swings related to the occluded upper airway) on the
clinical severity of asthma are poorly understood [1]. More-
over, the National Asthma Education and Prevention Program
Expert Panel Report recommends evaluating for OSA as a
potential contributor to poor asthma control [10]. Thus,
clarifying the nature of the relationship between OSAS and
asthma is a critical area with important therapeutic
implications.
Therefore, the aim of this study was: First, to assess the
prevalence of OSA in a group of asthmatics. Second, to eval-
uate the potential risk factors underlying the development of
OSA in these patients. Third, to determine the effect of this
overlap on asthma control.Table 1 Subjects’ characteristics.
Asthmatic patients Control p
Age 49.12 ± 3.43 47.8 ± 0.56 NS
Sex(M/F) 13/17 6/6 NS
BMI 28.13 ± 4.22 26.88 ± 2.42 NS
GERD n(%) 12(40) 2(15) <0.001*
Rhinitis/sinusitis 20(67) 3(25) <0.001***
ESS 8.89 ± 2.8 4.85 ± 2.15 <0.01**Patients and methods
30 patients with bronchial asthma were enrolled in the study.
Participants were recruited from consecutive patients present-
ing to asthma clinics of Alexandria. We included adults
(ageP 18 years) with a diagnosis of asthma of at least 12 mon-
th duration. Data were collected regarding demographic and
clinical factors, spirometry, general health information includ-
ing relevant comorbid conditions such as (Gastroesophageal
reﬂux disease (GERD), rhinitis or sinusitis) and current asth-
ma medication.
Patient control was assessed according to the latest GINA
guidelines and the level of control was divided into well con-
trolled, partly controlled or uncontrolled [11].
12 healthy adults matched for age, sex and BMI were
included as a control group. No sleep-related information
was used in the recruitment process.
Exclusion criteria for both groups included the following:
current smoker or ex-smoker with a greater than 10 pack-year
smoking history, comorbidities that could potentially interfere
with the study or other pulmonary diseases.Variables are expressed as mean ± standard deviation.
M= male, F = female, BMI = body mass index, GERD= gas-
troesophageal reﬂux disease, ESS = Epworth sleepiness scale,
NS = not signiﬁcant.
* Statistically signiﬁcant at p< 0.05.
** Statistically signiﬁcant at p< 0.01.
*** Statistically signiﬁcant at p< 0.001.Nocturnal sleep studies
All subjects underwent overnight polysomnography. The
patients underwent polysomnography at a time of relative
clinical stability, and at least 2 weeks after recovery from any
exacerbation or intervention.The analysis was carried out automatically and manually.
Respiratory events were scored using standard criteria [12].
The apnea hypopnea index (AHI) was deﬁned as the total
number of apneas and hypopneas per hour of sleep. As indices
of nocturnal hypoxemia we considered the oxygen desatura-
tion index (this is the number of times that the oxygen satura-
tion falls by more than 3 or 4 percent per hour of sleep), T90
(the fraction of sleep time spent below an oxygen saturation of
90%) and the minimal value recorded during sleep (minimal
SaO2). The OSA was deﬁned as an AHI of P5 events/h.
Assessment of daytime sleepiness
The Epworth Sleepiness Scale (ESS) was used for assessing
daytime sleepiness. This is a commonly used self-administered
scale with eight items about how easily the respondent would
fall asleep in different situations. The items are scored on a
0–3 scale, which are added to give an overall score of 0–24.
Higher scores indicate more sleepiness. ESS score 2–10 is con-
sidered ‘normal’ and >10 indicative of pathological sleepiness
[13].
All subjects were enrolled in the study after a written
informed consent according to a protocol approved by the
Ethics Committee of the Hospital.
Results
Subjects’ characteristics
30 asthmatic patients and 12 healthy controls matched for age,
sex and BMI were enrolled in the study. Subjects’ characteris-
tics are shown in Table 1. Asthmatic patients showed sig-
niﬁcantly more comorbidities, snoring and ESS.
Polysomnographic respiratory parameters of the studied subjects
OSA, deﬁned by an AHI of P5 events/h, was signiﬁcantly
more prevalent in the asthmatics in comparison with the con-
trol group (p< 0.001). The polysomnographic parameters of
the studied subjects are shown in Table 2.
Table 2 Polysomnographic respiratory parameters of the
studied subjects.
Asthmatic patients Control p
AHI P5 18(60) 1(8) <0.001***
AHI 19.5 ± 12.2 3.11 ± 1.4 <0.001***
ODI 6.48 ± 7.8 1.6 ± 1.1 <0.01**
T90(% TST) 5.9 ± 3.2 0.8 ± 1.4 <0.021*
Mean SaO2 92.4 ± 2.6 95.7 ± 1.8 NS
Min. SaO2 87.1 ± 1.9 90.8 ± 1.03 NS
Variables are expressed as mean ± standard deviation.
AHI = apnea hypopnea index, ODI = oxygen desaturation index,
NS = not signiﬁcant .
* Statistically signiﬁcant at p< 0.05.
** Statistically signiﬁcant at p< 0.01.
*** Statistically signiﬁcant at p< 0.001.
Table 4 Linear regression model of factors predictive of the
occurrence of OSA in asthmatics.
b# ± SD p value
BMI 0.058 ± 0.0.025 0.03*
GERD 1.192 ± 0.522 0.034*
FEV1 0.128 ± 0.031 0.001**
The presence of OSA is the dependant variable. Adjusted
R2 = 0.744. #b= the regression cooefﬁcient.
BMI = body mass index, GERD= gastroesophageal reﬂux
disease.
* Statistically signiﬁcant at p< 0.05.
** Statistically signiﬁcant at p< 0.01.
Table 5 Correlation between comorbid OSA and asthma
control.
Control Non OSA OSA
Well controlled 50% 5.6%
Partly controlled 33.3% 61%
Uncontrolled 16.7% 33.3%
X2 39.2
p <0.001***
X2 chi square test.
*** Statistically signiﬁcant at p< 0.001.
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Asthmatic patients with OSA had higher BMI, more comorbid
GERD and worse FEV1% (Table 3).
Predictors of the occurrence of OSA (deﬁned by an AHI ofP5
events/h) in asthmatic patients
Regression analysis revealed that high body mass index (BMI),
coexistent gastroesophageal reﬂux disease (GERD) and asthma
severity (FEV1%) are signiﬁcant independent predictors for the
development of OSA in asthmatics, independent of each other
(p= 0.03, 0.034, and <0.001 respectively) (Table 4).
Relation between the presence of OSA and the level of control in
the asthmatic patients
The presence of OSA in asthmatic patients was signiﬁcantly
associated with worse asthma control (p< 0.001) (Table 5).
Discussion
The primary ﬁnding from this study was that asthmatics are
more likely to develop OSA than non-asthmatics. Akhalil
using overnight polysomnography, we found a strikingly high
prevalence of OSA (deﬁned by an AHI of >5/h) in ourTable 3 Comparison between asthmatic patients with and without
Patients with OSA(18)
Age 52.1 ± 5.9
Sex(M/F) 6/12
BMI 29.2 ± 3.28
GERD n(%) 10(56)
Rhinitis/sinusitis 12(67)
FEV1 72.8 ± 4.8
ESS 10.22 ± 3.7
Variables are expressed as mean ± standard deviation.
M=male, F = female, BMI = body mass index, GERD= gastroeso
signiﬁcant.
* Statistically signiﬁcant at p< 0.05.
** Statistically signiﬁcant at p< 0.01.
*** Statistically signiﬁcant at p< 0.001.asthmatic group in comparison with the control group (60%
versus 17%, p< 0.001). A relationship between asthma and
OSA was noted >25 years ago [8]. Earlier studies suggested
that disturbed sleep in asthmatics was predominantly related
to poorly controlled nocturnal asthma [14,15] however, more
recent studies have found that symptoms of OSA, such as
snoring and witnessed apneas [2,16–18], are common in this
population. Furthermore, several studies have conﬁrmed that
asthmatic patients are more prone to develop OSAS symptoms
than are members of the general population. In the European
Community Health Respiratory Survey, self-reported habitual
snoring and apnea were signiﬁcantly more prevalent in asth-
matics as compared with non-asthmatics [19].
The gold standard for the diagnosis of OSA remains an
attended polysomnogram (PSG). However, there have been
few studies using current polysomnographic techniques to
assess OSAH prevalence among patients with asthma.
Polysomnographic studies report a high prevalence of OSAOSA.
Patients without OSA(12) p
47.3 ± 9.21 NS
7/5 NS
25.4 ± 4.37 0.003**
2(15) 0.023*
5(41) NS
78.2 ± 2.62 <0.001***
5.54 ± 2.15 <0.01**
phageal reﬂux disease, ESS = Epworth sleepiness scale, NS = not
428 M. Zidan et al.with more severe asthma, regardless of the methodology used.
In an earlier study of 22 difﬁcult to- control asthma patients
studied with laboratory based polysomnography, 21 (95.5%)
were diagnosed with OSA (respiratory disturbance indices
P5 with associated fatigue and EDS), and 9 (41%) had mod-
erate–severe OSA (respiratory disturbance indices P20) [20].
In a more recent report using home-based complete overnight
polysomnography, OSA, deﬁned by an AHI P15 events/h of
scored using Chicago criteria, was present in 88% patients
with severe asthma, 58% patients with moderate asthma,
and 31% controls without asthma (v2: p< 0.001). Using
the more restrictive scoring criteria applied in the Wisconsin
cohort study, AHI P5/h was present in 50% (severe), 23%
(moderate), and 12% (control) of subjects (p= 0.007) [3]. In
both studies, the very high prevalence of OSA in severe asth-
matics was unexpected for the degree of excess bodyweight
observed (mean BMI 29 and 27 kg/m2, respectively).
Obstructive sleep apnea (OSA) and asthma are potentially
linked at several levels. The pathophysiology of these two con-
ditions seems to overlap signiﬁcantly, as airway obstruction,
inﬂammation, obesity, and several other factors are implicated
in the development of both diseases [5]. Frequent nocturnal
asthma attacks may result in sleep deprivation and fragmenta-
tion of sleep that could lead to increased upper airway collapsi-
bility during sleep [21]. Recent data reporting a very high rate
of OSA in a small group of severe asthmatic patients on chron-
ic or intermittent systemic steroids suggest that the use of sys-
temic steroids may increase upper airway collapsibility.
Moreover, comorbid conditions which are closely associated
with asthma such as Gastroesophageal reﬂux disease (GERD),
obesity itself, cardiovascular complications, rhinitis and sinusi-
tis are all complex contributory factors that provide hypo-
thetical links [2,6].
In order to clarify the underlying factors predisposing to
the occurrence of OSA in asthmatic patients, we compared dif-
ferent demographic and clinical factors as well as comorbid
conditions and asthma severity between asthmatic patients
with and without OSA. Furthermore, we performed a regres-
sion mode to determine the underlying independent predictors
for the occurrence of OSA in asthmatic patients. We have
found that patients who had OSA had more coexistent GERD,
higher BMI and worse FEV1% (p< 0.001) than other asth-
matic patients. These factors were also found to be signiﬁcant
independent predictors of the occurrence of OSA in asthmatic
patients in the regression model.
GERD is commonly encountered in asthma, in many cases
being asymptomatic. 56% of asthmatic patients who had OSA
had GERD symptoms in comparison with 15% in the non
OSA group (p= 0.023). Moreover, GERD was found to be
an independent predictor for the occurrence of OSA in these
patients (p= 0.034). Pharyngeal spasm and mucosal exudative
neurogenic inﬂammation occurring as a result of proximal
migration of gastric acid and prolonged acid clearance during
sleep could render the upper airway dysfunctional and prone
to collapse during sleep [22]. Additionally, nocturnal GER
can cause arousal during sleep leading to sleep fragmentation
and upper airway edema promoting the expression of OSA
[23]. All these mechanisms may set the scene for the develop-
ment of OSA in these patients [1,7].
The mean BMI in our asthmatic group was 28.13 indicating
that they were on average overweight and obesity, consistentwith previous reports of excess weight among asthmatics. Obe-
sity is an independent risk factor for asthma and a dose
response effect of increasing body mass index (BMI) on
increasing risk of incident asthma has been shown [24].
Moreover, excess weight gain may occur in asthmatic, due to
a limited ability to exercise, sleep deprivation with increased
insulin resistance, depression, or the use of oral steroids [6].
In our previous study we have found a high prevalence of over-
weight and obesity in asthmatic patients (64% of the studied
group) [25]. In this study, the BMI of asthmatic patients with
OSA was signiﬁcantly higher than those without (29.2 versus
25.4, p= 0.003). Moreover, excess weight (higher BMI) was
found to be a signiﬁcant independent predictor of the develop-
ment of OSA in asthmatics (p= 0.03).
The rampant epidemic of obesity, particularly observed in
asthma patients, is likely to promote OSA [9]. Obesity is the
strongest risk factor for OSA and may affect breathing in sev-
eral ways, including a change in structure or function (collapsi-
bility) of the upper airway through increased fat deposition in
the pharyngeal wall from weight gain, reductions in functional
residual capacity, an increase in oxygen demand, and a change
in the respiratory drive and load compensation relationship
[5,6].
Relationships among obesity, OSA, and asthma are likely
to be bidirectional and more complex than can be dissected
in our correlational study.
Asthma severity as determined by spirometry, was found to
be a strong predictor of OSA (p< 0.001), indicating that the
increased prevalence of OSA in these patients is indeed linked
to mechanisms related to asthma itself. Our results add to the
evidence that asthma itself may lead to SDB, bronchoconstric-
tion reduces total airway cross-sectional area and is associated
with expiratory oropharyngeal and glottis constriction, possi-
bly as a result of intrapulmonary and chest wall reﬂexes [7].
Another reason behind this reduction is the permanent airway
mucosal inﬂammation observed in asthmatic patients. In fact,
Collett et al found a signiﬁcant reduction of upper airway
dimension during inspiration and expiration during asthma
ﬂares [26]. Also, asthma could deleteriously impact the patency
of the upper airway (UAW) through effects of sleep loss and
fragmentation which can increase airway collapsibility. More-
over, greater reduction in lung volumes during sleep, par-
ticularly during REM sleep [27,28]; decreased pharyngeal
transmural pressure related to nocturnal increase in air speed
[29]; and systemic inﬂammation-related weakening of respira-
tory muscles, which could include the UAW dilators are addi-
tional mechanisms [30,31].
Recent studies suggest that airway disease can be a linked
process (uniﬁed or linked airway) in selected patients. The
coexistence and hypothetical link between Cough/asthma,
Obesity/OSA, Rhinosinusitis, and Esophageal reﬂux was
recently referred to as the ‘‘CORE’’ syndrome. In asthmatic
patients refractory to therapy, CORE components must be
considered in the management [5].
A very important ﬁnding in this study is that the presence
of OSA in asthmatic patients was signiﬁcantly associated with
worse asthma control (p< 0.001).
Several pathways for OSA aggravation of asthma exist:
OSA increases the resistive load on the lower airways, superim-
posed on an already challenged airway, especially during sleep
[32]. Also, stimulation of upper airway receptors during the
Overlap of obstructive sleep apnea and bronchial asthma 429Mueller maneuvers of obstructive events could augment the
vagally mediated bronchoconstriction observed in asthmatics
and worsen bronchial hyperresponsiveness (BHR) through
alteration of the chemical arousal threshold or through resis-
tive loading [33]. Moreover, hypoxia could impair arousal
thresholds to resistive loading [34], cough [35], and asthma
symptom perception [36], all of which are important defenses
for these patients during sleep. OSA promotes GERD, which
is a well-recognized trigger of asthma. GERD can lead to
worsening of airway reactivity by directly inducing airway
inﬂammation or indirectly by enhancing vagal tone [5]. Final-
ly, inﬂammatory links may also be involved, where intermit-
tent hypoxia and distally transmitted mechanical stress from
snoring may exacerbate the lower airway inﬂammation in these
patients. In OSA patients, inﬂammation of the upper airway
has been well characterized, [37] while in the lower airway, a
neutrophilic type of inﬂammation has been demonstrated in
OSA patients, well correlated with disease severity [38]. Sys-
temically, OSA gives rise to a persistent state of inﬂammation,
which underlies its cardiovascular morbidity and also shares
features with the systemic inﬂammation of asthma [39]. These
observations raise the possibility that OSA, through local air-
way or systemic inﬂammation, may promote a non-eosinophi-
lic phenotype increasingly recognized among patients with
uncontrolled asthma [7,40,41].
In conclusion, a high index of suspicion is warranted for the
overlap of OSA and asthma, particularly in the presence of
obesity, GERD, and in patients with severe asthma. Indi-
vidualized therapy addressing moderating factors as weight
gain and GERD is warranted for optimal health outcomes.
Recognition and treatment of OSA in asthmatics is an impor-
tant element in improving asthma control. Further research is
needed to examine the long-term impact of therapy for OSA
on clinical outcomes in asthma.
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